Skip to main content

Weather Alert

Hurricane activity is severely impacting Quest locations across the Southeast. We ask that patients please double check your appointment status to ensure your designated Patient Service Center is operational.

Hide
Quest Diagnostics

The Importance of a Specimen Adequacy Control to Reduce False-Negative Mpox Virus Real-Time PCR Test Results

33rd European Congress of Clinical Microbiology and Infectious Diseases,

ECCMID 2023 Annual Meeting

Copenhagen, Denmark, April 15-18, 2023

Poster presentation: The Importance of a Specimen Adequacy Control to Reduce False-Negative Mpox Virus Real-Time PCR Test Results

Authors: Borillo GA, Kagan RM, Realegeno S, Marlowe EM

Specialties: Infectious disease

Related content

Publication
Identification of Human Mpox Virus Genome Deletions That Impact Diagnostic Assays
Test FAQ
Mpox Virus DNA, Qualitative Real-Time PCR

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.